Cite
HARVARD Citation
Spunt, S. et al. (2020). A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study. Lancet oncology. 21 (1), pp. 145-161. [Online].